4//SEC Filing
CORE LABORATORIES N V 4
Accession 0001000229-17-000057
CIK 0001000229operating
Filed
Apr 4, 8:00 PM ET
Accepted
Apr 5, 9:07 AM ET
Size
10.1 KB
Accession
0001000229-17-000057
Insider Transaction Report
Form 4
Dunlap Charles L
Director
Transactions
- Exercise/Conversion
Common Shares
2017-03-31+756→ 2,638 total - Tax Payment
Common Shares
2017-03-31$115.52/sh−4$462→ 2,634 total - Award
Restricted Shares
2017-04-01+1,299→ 1,299 totalExercise: $0.00→ Common Shares (1,299 underlying) - Exercise/Conversion
Restricted Shares
2017-03-31−756→ 0 totalExercise: $0.00→ Common Shares (756 underlying)
Footnotes (2)
- [F1]The Restricted Shares will vest, without performance criteria, at the end of a one-year vesting period ending April 1, 2018, subject to the terms of issuance.
- [F2]The Restricted Shares vested at the end of a three-year vesting period ending March 31, 2017.
Documents
Issuer
CORE LABORATORIES N V
CIK 0001000229
Entity typeoperating
IncorporatedNetherlands
Related Parties
1- filerCIK 0001000229
Filing Metadata
- Form type
- 4
- Filed
- Apr 4, 8:00 PM ET
- Accepted
- Apr 5, 9:07 AM ET
- Size
- 10.1 KB